4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-N-[(4-fluorophenyl)methyl]-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-N-[(4-fluorophenyl)methyl]-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-N-[(4-fluorophenyl)methyl]-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Compound characteristics
| Compound ID: | L310-2891 |
| Compound Name: | 4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-N-[(4-fluorophenyl)methyl]-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide |
| Molecular Weight: | 472.49 |
| Molecular Formula: | C22 H21 F N4 O5 S |
| Smiles: | Cc1cc2c(cc1S(NCc1ccc(cc1)F)(=O)=O)OCC(N2Cc1nc(C2CC2)on1)=O |
| Stereo: | ACHIRAL |
| logP: | 3.259 |
| logD: | 3.2583 |
| logSw: | -3.5333 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 99.018 |
| InChI Key: | AWYFOFZMOXUZKV-UHFFFAOYSA-N |